Gaithersburg-based Lab Awarded $1.6 Billion for COVID-19 Vaccine

by MCS Staff

Gaithersburg-based lab awarded $1.6 billion for COVID-19 vaccine.

Novavax Inc. is expected to deliver 100 million doses of their vaccine as early as the end of 2020, according to a press release. They will first conduct a clinical trial with up to 30,000 participants in the fall. Novavax will share their results from a smaller trial conducted in Australia at the end of July.

Novavax is participating in Operation Warp Speed, a federal program that aims to speed up the design and manufacturing of a COVID-19 vaccine. This $1.6 billion award is the program’s largest to date.

Stocks in Novavax increased by about 40 percent following the announcement.

By Prayag Gordy


You may also like

Leave a Comment


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy